A survival score for patients with metastatic spinal cord compression from prostate cancer.

Standard

A survival score for patients with metastatic spinal cord compression from prostate cancer. / Rades, D; Douglas, S; Veninga, T; Bajrovic, Amira; Stalpers, L J A; Hoskin, P J; Rudat, V; Schild, S E.

In: STRAHLENTHER ONKOL, Vol. 188, No. 9, 9, 2012, p. 802-806.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Rades, D, Douglas, S, Veninga, T, Bajrovic, A, Stalpers, LJA, Hoskin, PJ, Rudat, V & Schild, SE 2012, 'A survival score for patients with metastatic spinal cord compression from prostate cancer.', STRAHLENTHER ONKOL, vol. 188, no. 9, 9, pp. 802-806. <http://www.ncbi.nlm.nih.gov/pubmed/22526228?dopt=Citation>

APA

Rades, D., Douglas, S., Veninga, T., Bajrovic, A., Stalpers, L. J. A., Hoskin, P. J., Rudat, V., & Schild, S. E. (2012). A survival score for patients with metastatic spinal cord compression from prostate cancer. STRAHLENTHER ONKOL, 188(9), 802-806. [9]. http://www.ncbi.nlm.nih.gov/pubmed/22526228?dopt=Citation

Vancouver

Rades D, Douglas S, Veninga T, Bajrovic A, Stalpers LJA, Hoskin PJ et al. A survival score for patients with metastatic spinal cord compression from prostate cancer. STRAHLENTHER ONKOL. 2012;188(9):802-806. 9.

Bibtex

@article{af504d7d15de44af822dd759bdde731c,
title = "A survival score for patients with metastatic spinal cord compression from prostate cancer.",
abstract = "This study aimed to develop and validate a survival scoring system for patients with metastatic spinal cord compression (MSCC) from prostate cancer.",
keywords = "Adult, Comorbidity, Humans, Male, Aged, Middle Aged, Aged, 80 and over, Risk Factors, Treatment Outcome, Survival Rate, Prevalence, Age Distribution, Germany/epidemiology, Risk Assessment/methods, *Survival Analysis, *Proportional Hazards Models, Prostatic Neoplasms/*complications/mortality/radiotherapy, Spinal Cord Compression/*etiology/*mortality/prevention & control, Spinal Neoplasms/*complications/mortality/prevention & control/*secondary, Adult, Comorbidity, Humans, Male, Aged, Middle Aged, Aged, 80 and over, Risk Factors, Treatment Outcome, Survival Rate, Prevalence, Age Distribution, Germany/epidemiology, Risk Assessment/methods, *Survival Analysis, *Proportional Hazards Models, Prostatic Neoplasms/*complications/mortality/radiotherapy, Spinal Cord Compression/*etiology/*mortality/prevention & control, Spinal Neoplasms/*complications/mortality/prevention & control/*secondary",
author = "D Rades and S Douglas and T Veninga and Amira Bajrovic and Stalpers, {L J A} and Hoskin, {P J} and V Rudat and Schild, {S E}",
year = "2012",
language = "English",
volume = "188",
pages = "802--806",
journal = "STRAHLENTHER ONKOL",
issn = "0179-7158",
publisher = "Urban und Vogel",
number = "9",

}

RIS

TY - JOUR

T1 - A survival score for patients with metastatic spinal cord compression from prostate cancer.

AU - Rades, D

AU - Douglas, S

AU - Veninga, T

AU - Bajrovic, Amira

AU - Stalpers, L J A

AU - Hoskin, P J

AU - Rudat, V

AU - Schild, S E

PY - 2012

Y1 - 2012

N2 - This study aimed to develop and validate a survival scoring system for patients with metastatic spinal cord compression (MSCC) from prostate cancer.

AB - This study aimed to develop and validate a survival scoring system for patients with metastatic spinal cord compression (MSCC) from prostate cancer.

KW - Adult

KW - Comorbidity

KW - Humans

KW - Male

KW - Aged

KW - Middle Aged

KW - Aged, 80 and over

KW - Risk Factors

KW - Treatment Outcome

KW - Survival Rate

KW - Prevalence

KW - Age Distribution

KW - Germany/epidemiology

KW - Risk Assessment/methods

KW - Survival Analysis

KW - Proportional Hazards Models

KW - Prostatic Neoplasms/complications/mortality/radiotherapy

KW - Spinal Cord Compression/etiology/mortality/prevention & control

KW - Spinal Neoplasms/complications/mortality/prevention & control/secondary

KW - Adult

KW - Comorbidity

KW - Humans

KW - Male

KW - Aged

KW - Middle Aged

KW - Aged, 80 and over

KW - Risk Factors

KW - Treatment Outcome

KW - Survival Rate

KW - Prevalence

KW - Age Distribution

KW - Germany/epidemiology

KW - Risk Assessment/methods

KW - Survival Analysis

KW - Proportional Hazards Models

KW - Prostatic Neoplasms/complications/mortality/radiotherapy

KW - Spinal Cord Compression/etiology/mortality/prevention & control

KW - Spinal Neoplasms/complications/mortality/prevention & control/secondary

M3 - SCORING: Journal article

VL - 188

SP - 802

EP - 806

JO - STRAHLENTHER ONKOL

JF - STRAHLENTHER ONKOL

SN - 0179-7158

IS - 9

M1 - 9

ER -